Nan Fung Trinity (HK) Ltd holds a diversified book of 55 reported positions worth $1.0B as of Q2 2026 (disclosed Jul 24, 2026, a ~24-day 13F lag). This quarter Honeywell Aerospace Inc first appears in 13F filings, a listing rather than a purchase; they opened Iren Ltd and trimmed Advanced Micro Devices. Their largest long position is Advanced Micro Devices at 7% of the reported non-option book. Cloning the disclosed picks since 2024 would be +43% (+21.5%/yr). That is a simulation of the disclosed long book, not audited returns.
Following at the filing date actually beat the quarter-end book by 17.7 points over this window.
Growth of $10,000 cloning Nan Fung Trinity (HK) Ltd's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~24 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
88% mapped to company sectors
+1 sector below the cut, 1% together
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices (an exit at the prior quarter-end), no cost basis
Other tracked managers holding the same core names as Nan Fung Trinity (HK) Ltd
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| Hoey Investments, Inc | 11 / 55 | $327.8M |
| Lynch Asset Management, Inc. | 6 / 55 | $149.0M |
| Kemnay Advisory Services Inc. | 25 / 55 | $291.5M |
| Nelson Capital Management, LLC | 5 / 55 | $326.2M |
| Brookmont Capital Management | 5 / 55 | $64.8M |
| Hound Partners, LLC | 5 / 55 | $289.6M |
| TCG Crossover Management, LLC | 7 / 55 | $1.4B |
| KRS Capital Management, LLC | 7 / 55 | $71.1M |
Ranked by the share of each fund's own book sitting in the names it shares with Nan Fung Trinity (HK) Ltd: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.
Bars show each position's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Advanced Micro Devices Inc COM | $67.8M | 116.7K | 6.7% | ▼−28% Reduced · −45K sh | |
| 2 | Amcor PLC COM NEW | $52.0M | 1.20M | 5.1% | ▲+7.5% Added · +84K sh | |
| 3 | PPG Inds Inc COM | $48.2M | 397.3K | 4.8% | —Held | |
| 4 | Ge Healthcare Technologies I COMMON STOCK | $40.9M | 638.7K | 4.0% | ▲+203% Added · +428K sh | |
| 5 | Nvidia Corporation COM | $36.1M | 180.2K | 3.6% | ▼−22% Reduced · −50K sh | |
| 6 | Home Depot Inc COM | $35.2M | 99.9K | 3.5% | ▲+37% Added · +27K sh | |
| 7 | KT Corp SPONSORED ADR | $33.8M | 1.96M | 3.3% | ▲+0.3% Added · +5K sh | |
| 8 | Ishares TR MSCI INDONIA ETF | $33.7M | 2.98M | 3.3% | ▲+33% Added · +745K sh | |
| 9 | Ishares TR MBS ETF | $33.0M | 349.2K | 3.3% | —Held | |
| 10 | Owens Corning New COM | $29.6M | 186.3K | 2.9% | ▲+37% Added · +50K sh | |
| 11 | Unitedhealth Group Inc COM | $28.4M | 68.3K | 2.8% | ▼−34% Reduced · −36K sh | |
| 12 | Air Products And Chemicals I COM | $28.3M | 96.7K | 2.8% | —Held | |
| 13 | Ishares TR CORE S&P MCP ETF | $27.7M | 359.0K | 2.7% | —Held | |
| 14 | America Movil SAB De CV SPON ADS RP CL B | $27.4M | 1.06M | 2.7% | ▼−20% Reduced · −267K sh | |
| 15 | Mirum Pharmaceuticals Inc COM | $27.2M | 232.7K | 2.7% | —Held | |
| 16 | Danaher Corp Del COM | $24.1M | 126.5K | 2.4% | ▲+28% Added · +28K sh | |
| 17 | Trevi Therapeutics Inc COM | $22.6M | 1.21M | 2.2% | ▲+6.2% Added · +71K sh | |
| 18 | Meta Platforms Inc CL A | $21.0M | 37.4K | 2.1% | ▲+146% Added · +22K sh | |
| 19 | Protagonist Therapeutics Inc COM | $19.7M | 160.7K | 1.9% | —Held | |
| 20 | Abivax Sa SPONSORED ADS | $18.9M | 142.1K | 1.9% | ▲+10% Added · +13K sh | |
| 21 | SPDR Series Trust ST STR SP HOME | $17.9M | 155.0K | 1.8% | —Held | |
| 22 | Jd.com Inc SPON ADS CL A | $16.6M | 649.7K | 1.6% | —Held | |
| 23 | Bridgebio Pharma Inc COM | $16.3M | 219.2K | 1.6% | —Held | |
| 24 | MP Materials Corp COM CL A | $15.9M | 283.1K | 1.6% | —Held | |
| 25 | PDD Holdings Inc SPONSORED ADS | $15.8M | 207.7K | 1.6% | ▲+36% Added · +55K sh | |
| 26 | Scholar Rock Hldg Corp COM | $15.7M | 285.5K | 1.6% | —Held | |
| 27 | Warner Bros Discovery Inc COM SER A | $15.3M | 575.7K | 1.5% | —Held | |
| 28 | Immunome Inc COM | $15.1M | 714.6K | 1.5% | —Held | |
| 29 | Xenon Pharmaceuticals Inc COM | $15.0M | 247.8K | 1.5% | —Held | |
| 30 | Iren Limited ORDINARY SHARES | $13.5M | 295.0K | 1.3% | ▲New New position | |
| 31 | Kura Oncology Inc COM | $12.9M | 1.17M | 1.3% | ▲+10% Added · +110K sh | |
| 32 | Bicara Therapeutics Inc COM | $12.7M | 427.9K | 1.3% | —Held | |
| 33 | Alexandria Real Estate Eq In COM | $12.6M | 239.0K | 1.2% | —Held | |
| 34 | Honeywell Intl Inc COM | $12.3M | 55.1K | 1.2% | ▲New New position | |
| 35 | Honeywell Aerospace Inc COM | $12.2M | 55.1K | 1.2% | →Listed Newly reportable | |
| 36 | Vor Biopharma Inc COM NEW | $11.9M | 646.5K | 1.2% | ▲New New position | |
| 37 | Flex Ltd ORD | $11.7M | 72.3K | 1.2% | ▲New New position | |
| 38 | CRH PLC ORD | $11.4M | 106.7K | 1.1% | ▲New New position | |
| 39 | Savara Inc COM | $11.3M | 1.84M | 1.1% | —Held | |
| 40 | Celcuity Inc COM | $10.9M | 103.8K | 1.1% | —Held | |
| 41 | BXP Inc COM | $8.1M | 121.9K | 0.8% | —Held | |
| 42 | Kilroy Realty Corp COM | $7.9M | 210.8K | 0.8% | —Held | |
| 43 | Vaxcyte Inc COM | $7.1M | 122.9K | 0.7% | —Held | |
| 44 | SL Green Rlty Corp COM | $6.9M | 132.5K | 0.7% | ▼−2.4% Reduced · −3K sh | |
| 45 | Zai Lab Ltd ADR | $6.6M | 346.5K | 0.6% | —Held | |
| 46 | Abeona Therapeutics Inc COM NEW | $5.9M | 956.8K | 0.6% | —Held | |
| 47 | Vornado Rlty TR SH BEN INT | $5.7M | 143.8K | 0.6% | —Held | |
| 48 | Uniqure NV SHS | $5.3M | 115.5K | 0.5% | —Held | |
| 49 | Climb Bio Inc COM | $4.7M | 360.7K | 0.5% | ▼−14% Reduced · −60K sh | |
| 50 | Biocryst Pharmaceuticals Inc COM | $4.5M | 450.0K | 0.4% | ▲New New position |
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1781880/holdings"
Use Arkolith to show NAN FUNG TRINITY (HK) Ltd's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Reported 13F total per quarter. Raw filing totals can include option notional.
| Quarter | As of | Filed | Lag | Positions | Value | Form |
|---|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Jul 24, 2026 | 24d | 55 | $1.0B | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 5, 2026 | 35d | 62 | $910.6M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 4, 2026 | 35d | 78 | $1.3B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 4, 2025 | 35d | 71 | $1.0B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 8, 2025 | 39d | 59 | $835.8M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 8, 2025 | 38d | 39 | $630.5M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 4, 2025 | 35d | 30 | $489.7M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 | 44d | 26 | $528.4M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. Book totals and portfolio weights cover reported non-option positions, which can include notes and warrants. Disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.